Loading…

Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA

The development of multiple drug resistance in tumor cells is a significant problem in cancer therapy. In human, one of the reasons causing the resistance is due to the overexpression of the mdr1 gene product, P-glycoprotein. In our study, we had developed multiple drug resistant HepG2 cell line (He...

Full description

Saved in:
Bibliographic Details
Published in:Life sciences (1973) 2000-09, Vol.67 (17), p.2117-2124
Main Authors: Chan, Judy Yuet-Wa, Chu, Andrew Chi-Yuen, Fung, Kwok-Pui
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c510t-4a4ece5728100b56d7bc11e447be8ef60a119010c27acf15b7e664ed1f5cac153
cites
container_end_page 2124
container_issue 17
container_start_page 2117
container_title Life sciences (1973)
container_volume 67
creator Chan, Judy Yuet-Wa
Chu, Andrew Chi-Yuen
Fung, Kwok-Pui
description The development of multiple drug resistance in tumor cells is a significant problem in cancer therapy. In human, one of the reasons causing the resistance is due to the overexpression of the mdr1 gene product, P-glycoprotein. In our study, we had developed multiple drug resistant HepG2 cell line (HepG2/DR). To reverse the resistance, HepG2-DR cells were treated with antisense RNA against mdr1 gene. Total RNA and protein were extracted from the transfected cells. Northern analysis showed that mRNA level of mdr1 was decreased whereas a reduction in P-glycoprotein was detected by Western blot. By using flow cytometry, the ability of intracellular doxorubicin retention increased and drug efflux decreased in the treated cells. The result also showed that the cellular sensitivity to doxorubicin, vincristine and methotrexate measured in IC 50 increased 83.3% 84.6% and 50% respectively. All these findings suggested that the expression of p-glycoprotein was successfully inhibited by antisense RNA and the drug resistance was reduced.
doi_str_mv 10.1016/S0024-3205(00)00798-0
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17643494</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0024320500007980</els_id><sourcerecordid>17643494</sourcerecordid><originalsourceid>FETCH-LOGICAL-c510t-4a4ece5728100b56d7bc11e447be8ef60a119010c27acf15b7e664ed1f5cac153</originalsourceid><addsrcrecordid>eNqFkc9O3DAQxi3UCraUR6DyqYJD6Exix7unCiEKSKit-udsOc5k11XipLaD2Cfp6zZhVyD10pOl8e-bb2Y-xk4RLhCw_PAdIBdZkYM8AzgHUKtlBgdsgUu1yqAs8BVbPCNH7E2MvwBASlUcsiNEkEqVuGB_7vzGVS653vO-4V-zdbu1_RD6RM5zehwCxTh_Gl_zQA8Uomlnsg7jeipEF5PxlubSZuyM5xsaTOo7w29puMm5pbaNvNrybmyT-1e1Jk_8rKsDnk8OyUXykfi3z5dv2evGtJFO9u8x-_np-sfVbXb_5ebu6vI-sxIhZcIIsiRVvkSASpa1qiwiCaEqWlJTgkFcAYLNlbENykpRWQqqsZHWWJTFMXu_6zut_HukmHTn4jyz8dSPUaMqRSFWYgLlDrShjzFQo4fgOhO2GkHPieinRPR8bg2gnxLRMOne7Q3GqqP6RbWPYAI-7gCa1nxwFHS0jqbj1C6QTbru3X8s_gLcXp0d</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17643494</pqid></control><display><type>article</type><title>Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA</title><source>ScienceDirect Freedom Collection</source><creator>Chan, Judy Yuet-Wa ; Chu, Andrew Chi-Yuen ; Fung, Kwok-Pui</creator><creatorcontrib>Chan, Judy Yuet-Wa ; Chu, Andrew Chi-Yuen ; Fung, Kwok-Pui</creatorcontrib><description>The development of multiple drug resistance in tumor cells is a significant problem in cancer therapy. In human, one of the reasons causing the resistance is due to the overexpression of the mdr1 gene product, P-glycoprotein. In our study, we had developed multiple drug resistant HepG2 cell line (HepG2/DR). To reverse the resistance, HepG2-DR cells were treated with antisense RNA against mdr1 gene. Total RNA and protein were extracted from the transfected cells. Northern analysis showed that mRNA level of mdr1 was decreased whereas a reduction in P-glycoprotein was detected by Western blot. By using flow cytometry, the ability of intracellular doxorubicin retention increased and drug efflux decreased in the treated cells. The result also showed that the cellular sensitivity to doxorubicin, vincristine and methotrexate measured in IC 50 increased 83.3% 84.6% and 50% respectively. All these findings suggested that the expression of p-glycoprotein was successfully inhibited by antisense RNA and the drug resistance was reduced.</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/S0024-3205(00)00798-0</identifier><identifier>PMID: 11057761</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Antineoplastic Agents - pharmacokinetics ; Antineoplastic Agents - toxicity ; Antisense nucleic acid ; ATP Binding Cassette Transporter, Subfamily B, Member 1 - drug effects ; ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics ; Carcinoma, Hepatocellular ; Cell Survival - drug effects ; Cloning, Molecular ; doxorubicin ; Doxorubicin - pharmacokinetics ; Doxorubicin - toxicity ; Drug Resistance, Multiple - genetics ; Gene Expression Regulation, Neoplastic - drug effects ; Gene Expression Regulation, Neoplastic - physiology ; Humans ; Liver Neoplasms ; mdr1 gene ; methotrexate ; Methotrexate - pharmacokinetics ; Methotrexate - toxicity ; Multiple drug resistance ; P-glycoprotein ; RNA, Antisense - genetics ; RNA, Antisense - pharmacology ; Transcription, Genetic - drug effects ; Transfection - methods ; Tumor Cells, Cultured ; vincristine ; Vincristine - pharmacokinetics ; Vincristine - toxicity</subject><ispartof>Life sciences (1973), 2000-09, Vol.67 (17), p.2117-2124</ispartof><rights>2000 Elsevier Science Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c510t-4a4ece5728100b56d7bc11e447be8ef60a119010c27acf15b7e664ed1f5cac153</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11057761$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chan, Judy Yuet-Wa</creatorcontrib><creatorcontrib>Chu, Andrew Chi-Yuen</creatorcontrib><creatorcontrib>Fung, Kwok-Pui</creatorcontrib><title>Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA</title><title>Life sciences (1973)</title><addtitle>Life Sci</addtitle><description>The development of multiple drug resistance in tumor cells is a significant problem in cancer therapy. In human, one of the reasons causing the resistance is due to the overexpression of the mdr1 gene product, P-glycoprotein. In our study, we had developed multiple drug resistant HepG2 cell line (HepG2/DR). To reverse the resistance, HepG2-DR cells were treated with antisense RNA against mdr1 gene. Total RNA and protein were extracted from the transfected cells. Northern analysis showed that mRNA level of mdr1 was decreased whereas a reduction in P-glycoprotein was detected by Western blot. By using flow cytometry, the ability of intracellular doxorubicin retention increased and drug efflux decreased in the treated cells. The result also showed that the cellular sensitivity to doxorubicin, vincristine and methotrexate measured in IC 50 increased 83.3% 84.6% and 50% respectively. All these findings suggested that the expression of p-glycoprotein was successfully inhibited by antisense RNA and the drug resistance was reduced.</description><subject>Antineoplastic Agents - pharmacokinetics</subject><subject>Antineoplastic Agents - toxicity</subject><subject>Antisense nucleic acid</subject><subject>ATP Binding Cassette Transporter, Subfamily B, Member 1 - drug effects</subject><subject>ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics</subject><subject>Carcinoma, Hepatocellular</subject><subject>Cell Survival - drug effects</subject><subject>Cloning, Molecular</subject><subject>doxorubicin</subject><subject>Doxorubicin - pharmacokinetics</subject><subject>Doxorubicin - toxicity</subject><subject>Drug Resistance, Multiple - genetics</subject><subject>Gene Expression Regulation, Neoplastic - drug effects</subject><subject>Gene Expression Regulation, Neoplastic - physiology</subject><subject>Humans</subject><subject>Liver Neoplasms</subject><subject>mdr1 gene</subject><subject>methotrexate</subject><subject>Methotrexate - pharmacokinetics</subject><subject>Methotrexate - toxicity</subject><subject>Multiple drug resistance</subject><subject>P-glycoprotein</subject><subject>RNA, Antisense - genetics</subject><subject>RNA, Antisense - pharmacology</subject><subject>Transcription, Genetic - drug effects</subject><subject>Transfection - methods</subject><subject>Tumor Cells, Cultured</subject><subject>vincristine</subject><subject>Vincristine - pharmacokinetics</subject><subject>Vincristine - toxicity</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqFkc9O3DAQxi3UCraUR6DyqYJD6Exix7unCiEKSKit-udsOc5k11XipLaD2Cfp6zZhVyD10pOl8e-bb2Y-xk4RLhCw_PAdIBdZkYM8AzgHUKtlBgdsgUu1yqAs8BVbPCNH7E2MvwBASlUcsiNEkEqVuGB_7vzGVS653vO-4V-zdbu1_RD6RM5zehwCxTh_Gl_zQA8Uomlnsg7jeipEF5PxlubSZuyM5xsaTOo7w29puMm5pbaNvNrybmyT-1e1Jk_8rKsDnk8OyUXykfi3z5dv2evGtJFO9u8x-_np-sfVbXb_5ebu6vI-sxIhZcIIsiRVvkSASpa1qiwiCaEqWlJTgkFcAYLNlbENykpRWQqqsZHWWJTFMXu_6zut_HukmHTn4jyz8dSPUaMqRSFWYgLlDrShjzFQo4fgOhO2GkHPieinRPR8bg2gnxLRMOne7Q3GqqP6RbWPYAI-7gCa1nxwFHS0jqbj1C6QTbru3X8s_gLcXp0d</recordid><startdate>20000915</startdate><enddate>20000915</enddate><creator>Chan, Judy Yuet-Wa</creator><creator>Chu, Andrew Chi-Yuen</creator><creator>Fung, Kwok-Pui</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope></search><sort><creationdate>20000915</creationdate><title>Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA</title><author>Chan, Judy Yuet-Wa ; Chu, Andrew Chi-Yuen ; Fung, Kwok-Pui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c510t-4a4ece5728100b56d7bc11e447be8ef60a119010c27acf15b7e664ed1f5cac153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Antineoplastic Agents - pharmacokinetics</topic><topic>Antineoplastic Agents - toxicity</topic><topic>Antisense nucleic acid</topic><topic>ATP Binding Cassette Transporter, Subfamily B, Member 1 - drug effects</topic><topic>ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics</topic><topic>Carcinoma, Hepatocellular</topic><topic>Cell Survival - drug effects</topic><topic>Cloning, Molecular</topic><topic>doxorubicin</topic><topic>Doxorubicin - pharmacokinetics</topic><topic>Doxorubicin - toxicity</topic><topic>Drug Resistance, Multiple - genetics</topic><topic>Gene Expression Regulation, Neoplastic - drug effects</topic><topic>Gene Expression Regulation, Neoplastic - physiology</topic><topic>Humans</topic><topic>Liver Neoplasms</topic><topic>mdr1 gene</topic><topic>methotrexate</topic><topic>Methotrexate - pharmacokinetics</topic><topic>Methotrexate - toxicity</topic><topic>Multiple drug resistance</topic><topic>P-glycoprotein</topic><topic>RNA, Antisense - genetics</topic><topic>RNA, Antisense - pharmacology</topic><topic>Transcription, Genetic - drug effects</topic><topic>Transfection - methods</topic><topic>Tumor Cells, Cultured</topic><topic>vincristine</topic><topic>Vincristine - pharmacokinetics</topic><topic>Vincristine - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chan, Judy Yuet-Wa</creatorcontrib><creatorcontrib>Chu, Andrew Chi-Yuen</creatorcontrib><creatorcontrib>Fung, Kwok-Pui</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chan, Judy Yuet-Wa</au><au>Chu, Andrew Chi-Yuen</au><au>Fung, Kwok-Pui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA</atitle><jtitle>Life sciences (1973)</jtitle><addtitle>Life Sci</addtitle><date>2000-09-15</date><risdate>2000</risdate><volume>67</volume><issue>17</issue><spage>2117</spage><epage>2124</epage><pages>2117-2124</pages><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>The development of multiple drug resistance in tumor cells is a significant problem in cancer therapy. In human, one of the reasons causing the resistance is due to the overexpression of the mdr1 gene product, P-glycoprotein. In our study, we had developed multiple drug resistant HepG2 cell line (HepG2/DR). To reverse the resistance, HepG2-DR cells were treated with antisense RNA against mdr1 gene. Total RNA and protein were extracted from the transfected cells. Northern analysis showed that mRNA level of mdr1 was decreased whereas a reduction in P-glycoprotein was detected by Western blot. By using flow cytometry, the ability of intracellular doxorubicin retention increased and drug efflux decreased in the treated cells. The result also showed that the cellular sensitivity to doxorubicin, vincristine and methotrexate measured in IC 50 increased 83.3% 84.6% and 50% respectively. All these findings suggested that the expression of p-glycoprotein was successfully inhibited by antisense RNA and the drug resistance was reduced.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>11057761</pmid><doi>10.1016/S0024-3205(00)00798-0</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0024-3205
ispartof Life sciences (1973), 2000-09, Vol.67 (17), p.2117-2124
issn 0024-3205
1879-0631
language eng
recordid cdi_proquest_miscellaneous_17643494
source ScienceDirect Freedom Collection
subjects Antineoplastic Agents - pharmacokinetics
Antineoplastic Agents - toxicity
Antisense nucleic acid
ATP Binding Cassette Transporter, Subfamily B, Member 1 - drug effects
ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics
Carcinoma, Hepatocellular
Cell Survival - drug effects
Cloning, Molecular
doxorubicin
Doxorubicin - pharmacokinetics
Doxorubicin - toxicity
Drug Resistance, Multiple - genetics
Gene Expression Regulation, Neoplastic - drug effects
Gene Expression Regulation, Neoplastic - physiology
Humans
Liver Neoplasms
mdr1 gene
methotrexate
Methotrexate - pharmacokinetics
Methotrexate - toxicity
Multiple drug resistance
P-glycoprotein
RNA, Antisense - genetics
RNA, Antisense - pharmacology
Transcription, Genetic - drug effects
Transfection - methods
Tumor Cells, Cultured
vincristine
Vincristine - pharmacokinetics
Vincristine - toxicity
title Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T19%3A05%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20P-glycoprotein%20expression%20and%20reversal%20of%20drug%20resistance%20of%20human%20hepatoma%20HepG2%20cells%20by%20multidrug%20resistance%20gene%20(mdr1)%20antisense%20RNA&rft.jtitle=Life%20sciences%20(1973)&rft.au=Chan,%20Judy%20Yuet-Wa&rft.date=2000-09-15&rft.volume=67&rft.issue=17&rft.spage=2117&rft.epage=2124&rft.pages=2117-2124&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/S0024-3205(00)00798-0&rft_dat=%3Cproquest_cross%3E17643494%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c510t-4a4ece5728100b56d7bc11e447be8ef60a119010c27acf15b7e664ed1f5cac153%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17643494&rft_id=info:pmid/11057761&rfr_iscdi=true